Atypical chemokine receptors: emerging therapeutic targets in cancer is a research paper published in Trends in Pharmacological Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA279398
NCATS NIH HHS
Grant: UL1 TR002535
NCI NIH HHS
Grant: R01 CA269644
NCI NIH HHS
Grant: R01 CA258302
National Institutes of Health
Grant: 5R01CA258302-04
The CD93 pathway and melanoma therapy
National Institutes of Health
Grant: 3UL1TR002535-03S1
NIH Prior Approval Process Professional
National Institutes of Health
American Cancer Society
FWCI
3.16
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals